The Preliminary final report was disappointing once again with RNO still burning cash but we can't be too far off seeing positive cash flow. Sales are finally going in the right direction but we need something else to kick things along.
An interview last week with the Rhinomed vice president of global sales and marketing Shane Duncan, he pointed out that two new products in late-stage development, which are extensions of the Mute platform are going to be presented at the NACDS Total Store Expo this month.
Here is what he said about the new product:
We are adding an aromatherapy-based decongestant to the Mute device, which will help customers with a cold to decongest and breathe better. We also are adding a sleep onset-promoting formulation, which will help calm and relax customers, assisting them to
fall asleep.
We will be presenting these new innovative lines at NACDS Total Store Expo this month, and they will be available in stores in early 2019.
I've been quite critical of Rhinomed in the past however could this be the cash cow in the making? No wonder Columbia Care have taken an interest.
Breathing Easy: Rhinomed’s Duncan highlights sales
- Forums
- ASX - By Stock
- RNO
- Next Phaze
Next Phaze
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RNO (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, MD & CEO
Anthony Noble
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online